 | • レポートコード：GIR-2104Z14532 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、バラシクロビル経口剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バラシクロビル経口剤の種類別市場規模（500mg錠、1000mg錠、300mg錠、その他）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・バラシクロビル経口剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Sandoz、Sun Pharmaceutical、Cipla、Mylan、Teva、Zydus Pharmaceuticals、West-Ward Pharmaceuticals、Time Cap Labs、Wockhardt、Apotex、Aurobindo Pharma、Jubilant Pharma、Lunan Pharmaceutical、Shandong Luoxin Pharmaceutical Group、Tasly ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：500mg錠、1000mg錠、300mg錠、その他 ・用途別分析2016年-2026年：病院、ドラッグストア ・バラシクロビル経口剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・バラシクロビル経口剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・バラシクロビル経口剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バラシクロビル経口剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・バラシクロビル経口剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Valacyclovir Oral market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Valacyclovir Oral size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Valacyclovir Oral market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Valacyclovir Oral market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
500mg Tablet
1000mg Tablet
300mg Tablet
Others
Market segment by Application can be divided into
Hospital
Drug Store
The key market players for global Valacyclovir Oral market are listed below:
GSK
Sandoz
Sun Pharmaceutical
Cipla
Mylan
Teva
Zydus Pharmaceuticals
West-Ward Pharmaceuticals
Time Cap Labs
Wockhardt
Apotex
Aurobindo Pharma
Jubilant Pharma
Lunan Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Tasly
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Valacyclovir Oral Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Valacyclovir Oral Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 500mg Tablet
1.2.3 1000mg Tablet
1.2.4 300mg Tablet
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Valacyclovir Oral Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Valacyclovir Oral Market Size & Forecast
1.4.1 Global Valacyclovir Oral Sales in Value (2016-2026))
1.4.2 Global Valacyclovir Oral Sales in Volume (2016-2026)
1.4.3 Global Valacyclovir Oral Price by Type (2016-2026) & (USD/Unit)
1.5 Global Valacyclovir Oral Production Capacity Analysis
1.5.1 Global Valacyclovir Oral Total Production Capacity (2016-2026)
1.5.2 Global Valacyclovir Oral Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Valacyclovir Oral Market Drivers
1.6.2 Valacyclovir Oral Market Restraints
1.6.3 Valacyclovir Oral Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Valacyclovir Oral Product and Services
2.1.4 GSK Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Valacyclovir Oral Product and Services
2.2.4 Sandoz Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sun Pharmaceutical
2.3.1 Sun Pharmaceutical Details
2.3.2 Sun Pharmaceutical Major Business
2.3.3 Sun Pharmaceutical Valacyclovir Oral Product and Services
2.3.4 Sun Pharmaceutical Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Cipla
2.4.1 Cipla Details
2.4.2 Cipla Major Business
2.4.3 Cipla Valacyclovir Oral Product and Services
2.4.4 Cipla Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Valacyclovir Oral Product and Services
2.5.4 Mylan Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Valacyclovir Oral Product and Services
2.6.4 Teva Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Zydus Pharmaceuticals
2.7.1 Zydus Pharmaceuticals Details
2.7.2 Zydus Pharmaceuticals Major Business
2.7.3 Zydus Pharmaceuticals Valacyclovir Oral Product and Services
2.7.4 Zydus Pharmaceuticals Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 West-Ward Pharmaceuticals
2.8.1 West-Ward Pharmaceuticals Details
2.8.2 West-Ward Pharmaceuticals Major Business
2.8.3 West-Ward Pharmaceuticals Valacyclovir Oral Product and Services
2.8.4 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Time Cap Labs
2.9.1 Time Cap Labs Details
2.9.2 Time Cap Labs Major Business
2.9.3 Time Cap Labs Valacyclovir Oral Product and Services
2.9.4 Time Cap Labs Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Wockhardt
2.10.1 Wockhardt Details
2.10.2 Wockhardt Major Business
2.10.3 Wockhardt Valacyclovir Oral Product and Services
2.10.4 Wockhardt Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business
2.11.3 Apotex Valacyclovir Oral Product and Services
2.11.4 Apotex Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Aurobindo Pharma
2.12.1 Aurobindo Pharma Details
2.12.2 Aurobindo Pharma Major Business
2.12.3 Aurobindo Pharma Valacyclovir Oral Product and Services
2.12.4 Aurobindo Pharma Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Jubilant Pharma
2.13.1 Jubilant Pharma Details
2.13.2 Jubilant Pharma Major Business
2.13.3 Jubilant Pharma Valacyclovir Oral Product and Services
2.13.4 Jubilant Pharma Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Lunan Pharmaceutical
2.14.1 Lunan Pharmaceutical Details
2.14.2 Lunan Pharmaceutical Major Business
2.14.3 Lunan Pharmaceutical Valacyclovir Oral Product and Services
2.14.4 Lunan Pharmaceutical Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Shandong Luoxin Pharmaceutical Group
2.15.1 Shandong Luoxin Pharmaceutical Group Details
2.15.2 Shandong Luoxin Pharmaceutical Group Major Business
2.15.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product and Services
2.15.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Tasly
2.16.1 Tasly Details
2.16.2 Tasly Major Business
2.16.3 Tasly Valacyclovir Oral Product and Services
2.16.4 Tasly Valacyclovir Oral Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Valacyclovir Oral Sales by Manufacturer
3.1 Global Valacyclovir Oral Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Valacyclovir Oral Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Valacyclovir Oral
3.4 Market Concentration Rate
3.4.1 Top 3 Valacyclovir Oral Manufacturer Market Share
3.4.2 Top 6 Valacyclovir Oral Manufacturer Market Share
3.5 Global Valacyclovir Oral Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Valacyclovir Oral Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Valacyclovir Oral Market Size by Region
4.1.1 Global Valacyclovir Oral Sales in Volume by Region (2016-2026)
4.1.2 Global Valacyclovir Oral Revenue by Region (2016-2026)
4.2 North America Valacyclovir Oral Revenue (2016-2026)
4.3 Europe Valacyclovir Oral Revenue (2016-2026)
4.4 Asia-Pacific Valacyclovir Oral Revenue (2016-2026)
4.5 South America Valacyclovir Oral Revenue (2016-2026)
4.6 Middle East and Africa Valacyclovir Oral Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Valacyclovir Oral Sales in Volume by Type (2016-2026)
5.2 Global Valacyclovir Oral Revenue by Type (2016-2026)
5.3 Global Valacyclovir Oral Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Valacyclovir Oral Sales in Volume by Application (2016-2026)
6.2 Global Valacyclovir Oral Revenue by Application (2016-2026)
6.3 Global Valacyclovir Oral Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Valacyclovir Oral Sales by Type (2016-2026)
7.2 North America Valacyclovir Oral Sales by Application (2016-2026)
7.3 North America Valacyclovir Oral Market Size by Country
7.3.1 North America Valacyclovir Oral Sales in Volume by Country (2016-2026)
7.3.2 North America Valacyclovir Oral Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Valacyclovir Oral Sales by Type (2016-2026)
8.2 Europe Valacyclovir Oral Sales by Application (2016-2026)
8.3 Europe Valacyclovir Oral Market Size by Country
8.3.1 Europe Valacyclovir Oral Sales in Volume by Country (2016-2026)
8.3.2 Europe Valacyclovir Oral Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Valacyclovir Oral Sales by Type (2016-2026)
9.2 Asia-Pacific Valacyclovir Oral Sales by Application (2016-2026)
9.3 Asia-Pacific Valacyclovir Oral Market Size by Region
9.3.1 Asia-Pacific Valacyclovir Oral Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Valacyclovir Oral Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Valacyclovir Oral Sales by Type (2016-2026)
10.2 South America Valacyclovir Oral Sales by Application (2016-2026)
10.3 South America Valacyclovir Oral Market Size by Country
10.3.1 South America Valacyclovir Oral Sales in Volume by Country (2016-2026)
10.3.2 South America Valacyclovir Oral Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Valacyclovir Oral Sales by Type (2016-2026)
11.2 Middle East & Africa Valacyclovir Oral Sales by Application (2016-2026)
11.3 Middle East & Africa Valacyclovir Oral Market Size by Country
11.3.1 Middle East & Africa Valacyclovir Oral Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Valacyclovir Oral Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Valacyclovir Oral Typical Distributors
12.3 Valacyclovir Oral Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Valacyclovir Oral Revenue by Type, (USD Million), 2021-2026
Table 2. Global Valacyclovir Oral Revenue by Application, (USD Million), 2021-2026
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Valacyclovir Oral Product and Services
Table 6. GSK Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sandoz Basic Information, Manufacturing Base and Competitors
Table 8. Sandoz Major Business
Table 9. Sandoz Valacyclovir Oral Product and Services
Table 10. Sandoz Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Sun Pharmaceutical Major Business
Table 13. Sun Pharmaceutical Valacyclovir Oral Product and Services
Table 14. Sun Pharmaceutical Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cipla Basic Information, Manufacturing Base and Competitors
Table 16. Cipla Major Business
Table 17. Cipla Valacyclovir Oral Product and Services
Table 18. Cipla Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Valacyclovir Oral Product and Services
Table 22. Mylan Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Basic Information, Manufacturing Base and Competitors
Table 24. Teva Major Business
Table 25. Teva Valacyclovir Oral Product and Services
Table 26. Teva Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Zydus Pharmaceuticals Major Business
Table 29. Zydus Pharmaceuticals Valacyclovir Oral Product and Services
Table 30. Zydus Pharmaceuticals Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. West-Ward Pharmaceuticals Major Business
Table 33. West-Ward Pharmaceuticals Valacyclovir Oral Product and Services
Table 34. West-Ward Pharmaceuticals Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Time Cap Labs Basic Information, Manufacturing Base and Competitors
Table 36. Time Cap Labs Major Business
Table 37. Time Cap Labs Valacyclovir Oral Product and Services
Table 38. Time Cap Labs Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 40. Wockhardt Major Business
Table 41. Wockhardt Valacyclovir Oral Product and Services
Table 42. Wockhardt Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Apotex Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Major Business
Table 45. Apotex Valacyclovir Oral Product and Services
Table 46. Apotex Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Aurobindo Pharma Major Business
Table 49. Aurobindo Pharma Valacyclovir Oral Product and Services
Table 50. Aurobindo Pharma Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Jubilant Pharma Major Business
Table 53. Jubilant Pharma Valacyclovir Oral Product and Services
Table 54. Jubilant Pharma Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Lunan Pharmaceutical Major Business
Table 57. Lunan Pharmaceutical Valacyclovir Oral Product and Services
Table 58. Lunan Pharmaceutical Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Shandong Luoxin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 60. Shandong Luoxin Pharmaceutical Group Major Business
Table 61. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product and Services
Table 62. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Tasly Basic Information, Manufacturing Base and Competitors
Table 64. Tasly Major Business
Table 65. Tasly Valacyclovir Oral Product and Services
Table 66. Tasly Valacyclovir Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Valacyclovir Oral Sales by Manufacturer (2019-2021e) & (K Units)
Table 68. Global Valacyclovir Oral Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Valacyclovir Oral, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Valacyclovir Oral Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Valacyclovir Oral Production Site of Key Manufacturer
Table 72. Global Valacyclovir Oral Sales by Region (2016-2021e) & (K Units)
Table 73. Global Valacyclovir Oral Sales by Region (2021-2026) & (K Units)
Table 74. Global Valacyclovir Oral Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Valacyclovir Oral Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Valacyclovir Oral Sales by Type (2016-2021e) & (K Units)
Table 77. Global Valacyclovir Oral Sales by Type (2021-2026) & (K Units)
Table 78. Global Valacyclovir Oral Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Valacyclovir Oral Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Valacyclovir Oral Price by Type (2016-2021e) & (USD/Unit)
Table 81. Global Valacyclovir Oral Price by Type (2021-2026) & (USD/Unit)
Table 82. Global Valacyclovir Oral Sales by Application (2016-2021e) & (K Units)
Table 83. Global Valacyclovir Oral Sales by Application (2021-2026) & (K Units)
Table 84. Global Valacyclovir Oral Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Valacyclovir Oral Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Valacyclovir Oral Price by Application (2016-2021e) & (USD/Unit)
Table 87. Global Valacyclovir Oral Price by Application (2021-2026) & (USD/Unit)
Table 88. North America Valacyclovir Oral Sales by Country (2016-2021e) & (K Units)
Table 89. North America Valacyclovir Oral Sales by Country (2021-2026) & (K Units)
Table 90. North America Valacyclovir Oral Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Valacyclovir Oral Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Valacyclovir Oral Sales by Type (2016-2021e) & (K Units)
Table 93. North America Valacyclovir Oral Sales by Type (2021-2026) & (K Units)
Table 94. North America Valacyclovir Oral Sales by Application (2016-2021e) & (K Units)
Table 95. North America Valacyclovir Oral Sales by Application (2021-2026) & (K Units)
Table 96. Europe Valacyclovir Oral Sales by Country (2016-2021e) & (K Units)
Table 97. Europe Valacyclovir Oral Sales by Country (2021-2026) & (K Units)
Table 98. Europe Valacyclovir Oral Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Valacyclovir Oral Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Valacyclovir Oral Sales by Type (2016-2021e) & (K Units)
Table 101. Europe Valacyclovir Oral Sales by Type (2021-2026) & (K Units)
Table 102. Europe Valacyclovir Oral Sales by Application (2016-2021e) & (K Units)
Table 103. Europe Valacyclovir Oral Sales by Application (2021-2026) & (K Units)
Table 104. Asia-Pacific Valacyclovir Oral Sales by Region (2016-2021e) & (K Units)
Table 105. Asia-Pacific Valacyclovir Oral Sales by Region (2021-2026) & (K Units)
Table 106. Asia-Pacific Valacyclovir Oral Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Valacyclovir Oral Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Valacyclovir Oral Sales by Type (2016-2021e) & (K Units)
Table 109. Asia-Pacific Valacyclovir Oral Sales by Type (2021-2026) & (K Units)
Table 110. Asia-Pacific Valacyclovir Oral Sales by Application (2016-2021e) & (K Units)
Table 111. Asia-Pacific Valacyclovir Oral Sales by Application (2021-2026) & (K Units)
Table 112. South America Valacyclovir Oral Sales by Country (2016-2021e) & (K Units)
Table 113. South America Valacyclovir Oral Sales by Country (2021-2026) & (K Units)
Table 114. South America Valacyclovir Oral Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Valacyclovir Oral Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Valacyclovir Oral Sales by Type (2016-2021e) & (K Units)
Table 117. South America Valacyclovir Oral Sales by Type (2021-2026) & (K Units)
Table 118. South America Valacyclovir Oral Sales by Application (2016-2021e) & (K Units)
Table 119. South America Valacyclovir Oral Sales by Application (2021-2026) & (K Units)
Table 120. Middle East & Africa Valacyclovir Oral Sales by Country (2016-2021e) & (K Units)
Table 121. Middle East & Africa Valacyclovir Oral Sales by Country (2021-2026) & (K Units)
Table 122. Middle East & Africa Valacyclovir Oral Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Valacyclovir Oral Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Valacyclovir Oral Sales by Type (2016-2021e) & (K Units)
Table 125. Middle East & Africa Valacyclovir Oral Sales by Type (2021-2026) & (K Units)
Table 126. Middle East & Africa Valacyclovir Oral Sales by Application (2016-2021e) & (K Units)
Table 127. Middle East & Africa Valacyclovir Oral Sales by Application (2021-2026) & (K Units)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Valacyclovir Oral Typical Distributors
Table 131. Valacyclovir Oral Typical Customers
List of Figures
Figure 1. Valacyclovir Oral Picture
Figure 2. Global Valacyclovir Oral Sales Market Share by Type in 2020
Figure 3. 500mg Tablet
Figure 4. 1000mg Tablet
Figure 5. 300mg Tablet
Figure 6. Others
Figure 7. Global Valacyclovir Oral Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Valacyclovir Oral Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Valacyclovir Oral Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Valacyclovir Oral Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Valacyclovir Oral Sales (2016-2026) & (K Units)
Figure 32. Global Valacyclovir Oral Production Capacity (2016-2026) & (K Units)
Figure 33. Global Valacyclovir Oral Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Valacyclovir Oral Market Drivers
Figure 35. Valacyclovir Oral Market Restraints
Figure 36. Valacyclovir Oral Market Trends
Figure 37. Global Valacyclovir Oral Sales Market Share by Manufacturer in 2020
Figure 38. Global Valacyclovir Oral Revenue Market Share by Manufacturer in 2020
Figure 39. Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Valacyclovir Oral Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Valacyclovir Oral Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Valacyclovir Oral Sales Market Share by Region (2016-2026)
Figure 43. Global Valacyclovir Oral Revenue Market Share by Region (2016-2026)
Figure 44. North America Valacyclovir Oral Revenue (2016-2026) & (USD Million)
Figure 45. Europe Valacyclovir Oral Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Valacyclovir Oral Revenue (2016-2026) & (USD Million)
Figure 47. South America Valacyclovir Oral Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Valacyclovir Oral Revenue (2016-2026) & (USD Million)
Figure 49. Global Valacyclovir Oral Sales Market Share by Type (2016-2026)
Figure 50. Global Valacyclovir Oral Revenue Market Share by Type (2016-2026)
Figure 51. Global Valacyclovir Oral Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Valacyclovir Oral Sales Market Share by Application (2016-2026)
Figure 53. Global Valacyclovir Oral Revenue Market Share by Application (2016-2026)
Figure 54. Global Valacyclovir Oral Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Valacyclovir Oral Sales Market Share by Country (2016-2026)
Figure 56. North America Valacyclovir Oral Revenue Market Share by Country (2016-2026)
Figure 57. North America Valacyclovir Oral Sales Market Share by Type (2016-2026)
Figure 58. North America Valacyclovir Oral Sales Market Share by Application (2016-2026)
Figure 59. Europe Valacyclovir Oral Sales Market Share by Country (2016-2026)
Figure 60. Europe Valacyclovir Oral Revenue Market Share by Country (2016-2026)
Figure 61. Europe Valacyclovir Oral Sales Market Share by Type (2016-2026)
Figure 62. Europe Valacyclovir Oral Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Valacyclovir Oral Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Valacyclovir Oral Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Valacyclovir Oral Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Valacyclovir Oral Sales Market Share by Application (2016-2026)
Figure 67. South America Valacyclovir Oral Sales Market Share by Country (2016-2026)
Figure 68. South America Valacyclovir Oral Revenue Market Share by Country (2016-2026)
Figure 69. South America Valacyclovir Oral Sales Market Share by Type (2016-2026)
Figure 70. South America Valacyclovir Oral Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Valacyclovir Oral Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Valacyclovir Oral Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Valacyclovir Oral Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Valacyclovir Oral Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のバラシクロビルHCl市場 2021：企業別、地域別、種類・用途別 The Valacyclovir HCl market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…- 世界の薬物検査用口腔液市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Test Oral Fluid Market The global Drug Test Oral Fluid market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のメルカプトプリン経口液剤市場 2021：企業別、地域別、種類・用途別 The Mercaptopurine Oral Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…